Longevity Businesses, Built as New Ventures.
TURN8 designs, builds, and operates longevity businesses as new ventures. Each is four distinct businesses under one roof: clinical, digital, supplements and advanced therapies, and the wellness and experience layer, each with its own economics and pace. We sequence them rather than capitalize all at once. We operate the venture through validation and stay until it stands on its own as a fundable company.
Request the Readiness & Ambition AssessmentA Venture-Building Practice for Longevity
TURN8 Longevity builds longevity businesses for institutions that have the demand but lack clinical infrastructure. It is the flagship sector practice of our Venture Building engine, created for this industry rather than borrowed from a general playbook.
The practice adds clinical governance to a venture build. Every build includes a Medical Director with final authority on clinical standards, an evidence-tier framework, and a measurement model of five functional-capacity domains. This separates a longevity venture from a wellness program and is the part an institution cannot assemble on its own.
We are not the clinical provider. We design, build, and operate the venture as a separately incorporated company, licensed in its own market, which you capitalize and own.
Every build is led by expert operators with shared accountability from day one, who own the business model, the validation, and the capital.
Why Longevity Businesses Underperform
The failure is structural, not clinical. A precision longevity business is four distinct businesses under one roof, and each behaves differently:
Clinical
The regulated medical facility, staffed and licensed as one, running the baseline and periodic deep assessments. Clinical credibility and the highest-value touchpoints.
Digital
Biological scoring, wearable and CGM integration, the member app, anomaly detection. The data and retention engine, and the compounding asset.
Supplements & Advanced Therapies
An evidence-tiered library and precision, biomarker-driven supplementation. The high-margin recurring engine.
Wellness (Experience)
The immersive, concierge, or executive-health layer. The acquisition and premium-yield engine.
All four businesses get built at once, at full scale, before demand is proven.
We build them in sequence. We validate demand and pricing with paying members first, then release capital based on evidence at each gate. Each engine runs on its own terms from the start so it can be judged independently.
The readiness assessment establishes where the risk actually sits in your market and your asset base.
Operators. Shared risk. Staged capital.
Four commitments define how we engage. They are the same four on every build.
Operator of Record
Our Strategic Operating Partner sits inside the venture during the build, with real authority over operating decisions. Our Medical Director holds final authority on clinical standards.
Shared Risk
We share the upside instead of earning only from the engagement. The structure varies by institution, but the principle remains: part of our earnings depends on the venture clearing its validation gates.
Staged Capital
Capital is released against milestones, not time. Stop-loss rules are agreed before the build begins, and cash burn to milestone is reported against them at every gate.
Paired Authority
A Medical Director and a Strategic Operating Partner, accountable together from day one. It closes the two gaps that sink longevity clinics.
Six Kinds of Institution
We build in the verticals where demand is real and the economics hold.
Hospitals & Healthcare Corporates
Diversifying revenue, retaining premium patients, and turning an existing executive-health programme into a genuine longevity platform.
Family Offices
Building longevity infrastructure for the principal family and key people, and, often, investing in the platform itself.
Sports Institutions
Clubs, federations, and academies turning fifteen years of daily monitoring into an asset that compounds.
Hospitality & Resort Groups
Turning an asset base and a willing audience into recurring membership revenue alongside the property P&L.
Beauty & Fashion Houses
Converting a transactional buyer into an enrolled member, with clinical governance a house cannot provide alone.
Luxury Real Estate Developers
Anchoring branded residences and master-planned communities with a clinical longevity platform, so health becomes a driver of price and absorption rather than an amenity.
Within those institutions, we build across the verticals where conviction and unit economics are strongest. These include athlete and performance longevity, executive longevity, female longevity, chronic-disease and survivorship longevity, family and multi-generational programs, destination longevity for resort and medical-tourism settings, and residential longevity for branded residences and master-planned communities.
Request the Readiness & Ambition AssessmentFrom Conviction to a Company That Stands on Its Own
We meet institutions where they are and move them forward only when the evidence justifies it.
For institutions building conviction. A board-ready case for or against entering the category: market read, benchmark against global platforms, Readiness & Ambition Assessment, and a concept note with a phased roadmap and indicative capital ladder.
For institutions with confirmed intent and pilot capital in place. A validation sprint in the real market includes customer discovery, pricing experiments, a first paying cohort, and unit economics tested against live data.
For institutions with board approval and committed capital, we take the venture from governance design through full launch. We stay until it is stable and fundable. You leave with a company that runs without us.
The Readiness & Ambition Assessment
The assessment evaluates six dimensions independently: clinical, commercial, operational, regulatory, capital, and resource availability.
| Dimension | What it measures |
|---|---|
| Clinical | Depth of clinical infrastructure, evidence-tiered guidelines, outcome measurement, multidisciplinary team model, geroscience advisors. |
| Commercial | Customer thesis, channels, and in-market willingness-to-pay evidence. |
| Operational | Ability to stand up and run a multi-engine venture — infrastructure, talent, supply chain, quality management, IP. |
| Regulatory | Licensing pathway, compliance posture, data governance, advanced-therapy positioning. |
| Capital | Committed CAPEX, investment committee, gate-based release, stop-loss rules. |
| Resource availability | Executive sponsor with real authority, access to clinical talent in-market, CTO and CFO bench. |
Paired Leadership, From Day One
Dr. Ana Baroni
Medical Strategy & Clinical Leadership, TURN8
MD, PhD in Molecular Diagnostics (Cum Laude), with over 27 years of clinical practice in precision, regenerative, functional, and integrative medicine. She is Chief Scientific Officer at Longevity.Tech.fund and Chief Medical Officer at HealthyLongevity.clinic.
At TURN8 Longevity, she serves as Medical Director on every build with final authority on clinical standards and care-team design. She defines what is clinically credible and investable.
Kamal Hassan
Managing Partner, TURN8 | Strategic Operating Partner, Longevity Ventures
A three-time founder who has designed and operated venture studios and CVC platforms for national champions, conglomerates, and government entities across the GCC, Europe, and the US.
At TURN8 Longevity, he owns the commercial half of every build: the business model, unit economics, go-to-market, and capital discipline that turns a longevity ambition into a fundable operating company.
Every build is backed by TURN8's venture-building practice: a CTO-in-Residence, a CFO-in-Residence, and a New Venture Board nominated by the client.
Request the Readiness & Ambition AssessmentFrequently Asked Questions
What is the longevity clinic business model, and why build a longevity clinic as a venture instead of a service line?
A longevity clinic is really four businesses under one roof — clinical, digital, supplements and advanced therapies, and the wellness or experience layer — each with its own economics and pace. We build them in sequence: validate demand and pricing with paying members first, then release capital based on evidence at each gate.
How do you build a longevity clinic in Saudi Arabia and the GCC?
In three stages: Learn (60–90 days), Test (90–180 days), and Deploy (18–36 months). Vision 2030 has created both the demand and the mandate in the Kingdom — closing the execution gap is what an operator-led model is for.
How much does it cost to build a longevity clinic?
Capital scales with the stage and is released against milestones rather than all at once, with stop-loss conditions agreed before the first tranche.
What does a longevity clinic charge members, and is it profitable?
Published annual memberships range from around €10,000 to over €100,000, with executive packages exceeding €150,000. Because no insurance billing code exists for healthspan extension, these are self-pay or contract-paid businesses.
What is precision longevity medicine, and how is it different from a wellness clinic or an executive health check?
Precision longevity medicine measures how much reserve a person holds in each of five functional-capacity domains, personalized to their own biology and tracked over time.
How does TURN8 govern clinical evidence and longevity claims?
Through an evidence-tier framework governed by Medical Director Dr. Ana Baroni, who holds final authority on clinical standards and care-team design.
Who is the longevity venture-building practice for?
Six kinds of institution: hospitals and healthcare corporates, family offices, sports institutions, hospitality and resort groups, beauty and fashion houses, and luxury real estate developers.
What is a longevity venture builder, and how is TURN8 different from a consultant?
A venture builder builds the clinic with you, operates the venture as a separately incorporated company you own, and shares the upside depending on validation gates.
Why is now the moment to enter the longevity market?
High-net-worth longevity spending is estimated above USD 50 billion annually, and anchor institutions are actively building. What remains scarce is the operating capability to build a clinic that lasts.
How do we get started with TURN8 Longevity?
Start with the Readiness & Ambition Assessment to evaluate clinical, commercial, operational, regulatory, capital, and resource dimensions.
Is the Opportunity Real for You?
A longevity venture measures what it changes, governs what it claims, and compounds into an asset you own. The assessment scores six dimensions: clinical, commercial, operational, regulatory, capital, and resource availability.
Request the Readiness & Ambition Assessment